EE125 Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Immunization Using Monoclonal Antibodies (mAB) in United States Infants: An Analysis of In-Season and out-of-Season Birth Cohorts
EPH72 Potential Adverse Effects of Passive Immunization Against Respiratory Syncytial Virus (RSV) in Low-Risk Infants in the United States
https://www.valueinhealthjournal.com/article/S1098-3015(22)01026-9/fulltext
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.